ClinicalTrials.gg
WithdrawnNCT05135481Updated Jul 21, 2022

Dedicated Lactation Support in Infants With Tongue - Tie; a Randomised Control Trial

An interventional study of phrenectomy and Increased lactation support in Ankyloglossia, Breast Feeding, Exclusive and Lactation Failure, sponsored by Princess Anna Mazowiecka Hospital, Warsaw, Poland. Withdrawn at 1 site in Poland. Open to participants aged 1 Minute to 48 Hours. Per ClinicalTrials.gov, last updated 2022-07-21.

Sponsored by Princess Anna Mazowiecka Hospital, Warsaw, Poland · Not applicable, Interventional, and Prevention

Why this study was withdrawn
recruitment problems
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
1 Minute to 48 Hours
Sex
All
01

Study summary

The investigators are registering a randomised controlled trial to assess whether dedicated, intensified lactation support is as good as frenotomy on the incidence of breastfeeding among term infants with ankyloglossia.

Read the detailed description

The investigators plan to include a total 316 infants. The study will be carried out in level III hospital in Warsaw, Poland. The primary outcome will be exclusive breastfeeding at 12 weeks of age. Secondary outcomes include breastfeeding > 50% of feedings, improved breastfeeding comfort as assessed by the mother, weight gain, head circumference and length gain, the need to use a breast pump or lactation accessories, time of breastfeeding cessation, the type of lactation, neurological and rehabilitation assistance received, the frequency of obtained lactation, neurological and rehabilitation assistance.

02

Conditions studied

  • Ankyloglossia
  • Breast Feeding, Exclusive
  • Lactation Failure
  • Tongue-tie
03

In context

Ankyloglossia

32 studies on the registry are indexed under Ankyloglossia; 8 are open to participants now.

Browse Ankyloglossia studies →

Lead sponsor

Princess Anna Mazowiecka Hospital, Warsaw, Poland is the lead sponsor of 14 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Minute to 48 Hours
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. full - term infants born with an Apgar score of 8-10 points
  2. no visual causes of lactation difficulties (malocclusion, posterior and small jaw, cervical torticollis, significant positional asymmetry)
  3. parental consent

Exclusion criteria

Exclusion criteria:

  1. hypotrophy
  2. low birth weight
  3. perinatal complications
  4. congenital craniofacial defects
  5. neurological diseases
  6. visible genetic syndromes
  7. mother' unwilling to breastfeed
  8. no consent for vaccination against
  9. neonates born to seropositive mothers
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hepatitis B tests

Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.

Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    CONTROL GROUP

    The qualification for phrenectomy in group 1 will be made based on the Amir scale, i.e. a score of 4 and fewer points for the language function.

    Procedure: phrenectomy

  • Experimental
    STUDY GROUP

    Management in group 2 will include increased lactation care both during hospital stay and post discharge. Increased lactation care will consist of: individual consultations on how to properly attach the baby to the breast (at least 3 meetings during hospitalization with personnel trained in lactation counselling), regular (at least once a week) contact with a breastfeeding consultant as part of a closed group on social media or by phone, if necessary (expressed by the mother or based on a referral by a member of the lactation team) an outpatient appointment at the breastfeeding clinic.

    Other: Increased lactation support

Interventions

  • Procedurephrenectomy

    The qualification for phrenectomy in group 1 will be made based on the Amir scale, i.e. a score of 4 and fewer points for the language function (2).

  • OtherIncreased lactation support

    Management in group 2 will include increased lactation care both during hospital stay and post discharge.

    Also known as: dedicated lactation support

06

What researchers measure

Primary outcomes

  1. Proportion of exclusively breastfeeding mothers

    Proportion of exclusively breastfeeding mothers

    Time frame: at 12 weeks of age

Secondary outcomes

  1. Proportion of mother-baby dyads with a breastfeeding frequency of > 50%.

    Proportion of mother-baby dyads with a breastfeeding frequency of \> 50% of feedings, which will be assessed using the Breastfeeding Self-Efficacy Scale Short Form \[9, 10\]

    Time frame: at 12 weeks of age

  2. Weight change

    Median weight change

    Time frame: at 12 weeks of age

  3. Head circumference change

    Median head circumference change

    Time frame: at 12 weeks of age

  4. Length change

    Median length change

    Time frame: at 12 weeks of age

  5. Incidence of using a breast pump or lactation accessories

    Proportion of mothers needing to use a breast pump or lactation accessories (e.g. nipple shields)

    Time frame: at 12 weeks of age

  6. Time of breastfeeding cessation

    median time of breastfeeding cessation

    Time frame: during 12 weeks of age

  7. Rate of additional consultations

    Rate of consultations (e.g. speech therapist, rehabilitants, other lactation consultants) received by a mother - baby dyads.

    Time frame: during 12 weeks of age

  8. Change in breastfeeding comfort

    Proportion of mothers reporting change in breastfeeding comfort

    Time frame: at 12 weeks of age

07

Study locations

1 site
  • Department of Neonatology and Neonatal Intensive Care Warsaw Medical University
    Warsaw, 00-315, Poland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05135481
Lead sponsor
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Responsible party
Sponsor
First posted
Nov 26, 2021
Start date
Mar 8, 2022
Primary completion
Dec 31, 2022 (estimated)
Completion
Mar 31, 2023 (estimated)
Last update
Jul 21, 2022

Study contacts

Joanna Seliga - Siwecka, MD PhD
study director · Medical University of Warsaw
Justyna Fiałkowska, MD
principal investigator · Medical University of Warsaw

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion